Jeremiah Stitham

Internal Medicine
64 Robbins St
Waterbury, CT 06708

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Loss of Macrophage mTORC2 Drives Atherosclerosis via FoxO1 and IL-1β Signaling.

Loss of Macrophage mTORC2 Drives Atherosclerosis via FoxO1 and IL-1β Signaling.

Journal: Circulation research
Published: June 23, 2023

Use of acidic nanoparticles to rescue macrophage lysosomal dysfunction in atherosclerosis.

Use of acidic nanoparticles to rescue macrophage lysosomal dysfunction in atherosclerosis.

Journal: Autophagy
Published: August 19, 2022

Evaluation of mTORC1 signaling in mouse atherosclerotic macrophages by flow cytometry and immunofluorescence.

Evaluation of mTORC1 signaling in mouse atherosclerotic macrophages by flow cytometry and immunofluorescence.

Journal: STAR protocols
Published: February 28, 2022

Identification of a leucine-mediated threshold effect governing macrophage mTOR signalling and cardiovascular risk.

Identification of a leucine-mediated threshold effect governing macrophage mTOR signalling and cardiovascular risk.

Journal: Nature metabolism
Published: February 23, 2022

Trehalose causes low-grade lysosomal stress to activate TFEB and the autophagy-lysosome biogenesis response.

Trehalose causes low-grade lysosomal stress to activate TFEB and the autophagy-lysosome biogenesis response.

Journal: Autophagy
Published: March 12, 2021

Inflammasomes: a preclinical assessment of targeting in atherosclerosis.

Inflammasomes: a preclinical assessment of targeting in atherosclerosis.

Journal: Expert opinion on therapeutic targets
Published: August 08, 2020

Inducing mitophagy in diabetic platelets protects against severe oxidative stress.

Inducing mitophagy in diabetic platelets protects against severe oxidative stress.

Journal: EMBO molecular medicine
Published: May 26, 2016

Prostacyclin, Atherothrombosis and Diabetes Mellitus: Physiologic and Clinical Considerations.

Prostacyclin, Atherothrombosis and Diabetes Mellitus: Physiologic and Clinical Considerations.

Journal: Current molecular medicine
Published: November 28, 2015

Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor.

Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor.

Journal: Blood
Published: January 05, 2015

Individual variation of human S1P₁ coding sequence leads to heterogeneity in receptor function and drug interactions.

Individual variation of human S1P₁ coding sequence leads to heterogeneity in receptor function and drug interactions.

Journal: Journal of lipid research
Published: October 09, 2014

Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies.

Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies.

Journal: Current molecular medicine
Published: April 23, 2014

Cardiovascular pharmacogenetics of anti-thrombotic agents and non-steroidal anti-inflammatory drugs.

Cardiovascular pharmacogenetics of anti-thrombotic agents and non-steroidal anti-inflammatory drugs.

Journal: Current molecular medicine
Published: March 24, 2014
Showing 1-12 of 15

Last Updated: 09/26/2026